Sara Silva received a BSc in Biomedical Science at the University of Algarve. She then took her Master's Degree in Cellular and Molecular Biology from the Faculty of Science of the University of Porto. Her master's thesis was developed at the Department of Chemistry and Biochemistry of the Faculty of Science, in collaboration with the Instituto Ricardo Jorge in Porto, where she aimed to develop new antimicrobial peptides against Mycobacterium tuberculosis. She had the opportunity to manually synthesise and characterise therapeutic peptides and work with human pathogens in a level 3 (P3) biosafety environment. In 2018, enrolled in the Doctoral Programme of Pharmaceutical Science of the Faculty of Pharmacy of the University of Porto. She was granted through the i3DU doctoral programme, a FCT doctoral grant to develop a dual-delivery system composed of cell-penetrating peptides and nanoparticles for biomedical applications. With an interdisciplinary background, Sara's expertise includes peptide synthesis, nanoparticle preparation, characterisation, and functionalisation, drug delivery, cell culture, and biomaterials. In 2023, she took a postdoctoral position in the Molecular Biomaterials Group, led by Dr Helena S. Azevedo, at i3S, where she developed an advanced in vitro blood-brain barrier model integrating self-assembling peptide–Hyaluronic Acid membranes and 3D printing. This also came with the opportunity to undertake an international visit to the group of Dr Joe Forth (University of Liverpool), gaining hands-on training in embedded 3D bioprinting. Currently, as a junior researcher in the Molecular Biomaterial group, I’m undertaking a new international research visit to the group of Dr Ahmed Ismail at the School of Engineering and Materials Sciences at Queen Mary University of London, acquiring expertise in electrospraying of peptide solutions to form suspended membranes and digital light synthesis (DLS) printing.